ArticleCancer chemotherapy and pharmacology2022

A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.

Wen Wee Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.